Advanced Surgical Simulation Processes in the Correction of Skeletal Defects and Deformities

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-40
SponsorIstituto Ortopedico Rizzoli

About this trial

Virtual Surgical Planning (VSP), Computer-Aided Surgical Simulation (CASS) for bone corrections, and the customization of implants and devices through 3D printing, known as Patient-Specific Instruments (PSI) and Graft-Specific Instruments (GSI), are assuming increasingly central roles in orthopedic clinical and surgical practice.

One area witnessing notable advancement is the treatment of musculoskeletal disorders (MMS) in children, adolescents, and young adults. These disorders involve severe and rare abnormalities in skeletal formation and development across three-dimensional planes, often affecting multiple limbs. Managing such deformities is complex, challenging to standardize, and prone to unpredictable clinical, radiographic, and functional outcomes.

The application of 3D modeling and printing technologies offers a deeper understanding of deformities and facilitates improved prediction, precision, reproducibility, and safety in surgical interventions.

The Musculoskeletal Apparatus Network (RAMS Network) centers are equipped with advanced 3D laboratories for surgical simulation and planning, aligned with the overarching goal of improving surgery quality through "in-silico" medicine (ISM) principles.

At present, numerous complex surgeries involving Virtual Surgical Planning (VSP) and sterilizable 3D-printed Patient-Specific Instruments (PSI) and/or Graft-Specific Instruments (GSI) are being simulated and performed at the Rizzoli Institute. Preliminary data from previous protocols indicate a significant reduction in surgical time with the implementation of VSP and the utilization of PSI and GSI.

The aim of this study is to enhance the current process of simulating, planning, and designing surgical support tools within 3D Printing Point-of-Care (3D POC) facilities. To achieve this, it is imperative to expand case volumes and systematically organize, categorize, and standardize simulation and planning procedures.

Eligibility criteria

Qualifiers

Diagnosis of musculoskeletal disease (MSD) of the limbs;

Need for mono- or polyaxial correction by one or more osteotomies;

Presence of specific consent to participate in the trial;

Disqualifiers

Patients who refuse to participate in the study

Patients who do not undergo radiological follow-up examinations for VSP or for whom the radiological record is insufficient to conduct VSP;

Patients who undergo different interventions for correction of MSD (growth modulation interventions by epiphysiodesis and hemiepiphysiodesis, progressive correction by external circular/hexapodal fixation);

Pregnant or lactating women

Trial design

Treatments tested in this trial

  • Deformity correction

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators

Istituto Ortopedico Rizzoli

Lead sponsor

Ospedale Pediatrico Bambino Gesù

Collaborator

Istituto Giannina Gaslini

Collaborator

Galeazzi Orthopedic Institute

Collaborator

Istituto Nazionale Tumori Regina Elena

Collaborator

Policlinico San Matteo

Collaborator

Istituto Clinico Humanitas

Collaborator